PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $183,173,899 | +19.1% | 5,286,404 | -0.5% | 2.84% | +24.9% |
Q1 2024 | $153,777,820 | +26.2% | 5,315,514 | 0.0% | 2.27% | +19.2% |
Q4 2023 | $121,884,736 | +34.9% | 5,315,514 | -1.8% | 1.90% | -0.1% |
Q3 2023 | $90,330,774 | -39.6% | 5,415,514 | 0.0% | 1.91% | -33.1% |
Q2 2023 | $149,576,497 | +41.4% | 5,415,514 | +17.7% | 2.85% | +29.2% |
Q1 2023 | $105,818,377 | +170.0% | 4,600,799 | +28.1% | 2.20% | +175.5% |
Q4 2022 | $39,188,567 | +11.3% | 3,591,986 | -14.0% | 0.80% | -1.5% |
Q3 2022 | $35,211,000 | -7.2% | 4,176,837 | -12.9% | 0.81% | -17.1% |
Q2 2022 | $37,924,000 | -66.6% | 4,794,499 | 0.0% | 0.98% | -58.3% |
Q1 2022 | $113,534,000 | +27.7% | 4,794,499 | +84.4% | 2.35% | +81.0% |
Q4 2021 | $88,914,000 | +186.1% | 2,599,822 | +48.2% | 1.30% | +176.8% |
Q3 2021 | $31,075,000 | -80.3% | 1,753,695 | -50.0% | 0.47% | -80.3% |
Q2 2021 | $157,412,000 | +73.3% | 3,507,390 | 0.0% | 2.38% | +67.5% |
Q1 2021 | $90,841,000 | +23.5% | 3,507,390 | -3.9% | 1.42% | +14.8% |
Q4 2020 | $73,585,000 | +10.4% | 3,650,069 | +7.1% | 1.24% | -23.1% |
Q3 2020 | $66,645,000 | +11.5% | 3,408,961 | +0.8% | 1.60% | -4.5% |
Q2 2020 | $59,747,000 | +218.1% | 3,383,208 | +27.2% | 1.68% | +108.0% |
Q1 2020 | $18,782,000 | +8.3% | 2,660,392 | +8.1% | 0.81% | +23.5% |
Q4 2019 | $17,343,000 | +89.4% | 2,459,988 | +222.7% | 0.65% | +20.2% |
Q3 2019 | $9,155,000 | – | 762,283 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $43,253,000 | 8.50% |
BVF INC/IL | 2,367,288 | $41,806,000 | 2.58% |
RTW INVESTMENTS, LP | 3,383,208 | $59,747,000 | 1.68% |
Novo Holdings A/S | 824,169 | $14,555,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,013,495 | $17,898,000 | 0.52% |
Sofinnova Investments, Inc. | 326,064 | $5,758,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $44,150,000 | 0.35% |
Virtus ETF Advisers LLC | 21,639 | $382,000 | 0.18% |
Baker Brothers Advisors | 1,911,446 | $33,756,000 | 0.15% |
King Wealth Management Group | 22,000 | $389,000 | 0.11% |